RP Bio Inc. (KOSDAQ:314140)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,410.00
+10.00 (0.16%)
At close: Mar 27, 2026
Market Cap55.55B +21.4%
Revenue (ttm)134.21B +4.7%
Net Income4.89B
EPS564.30
Shares Out8.67M
PE Ratio11.36
Forward PEn/a
Dividend50.00 (0.78%)
Ex-Dividend DateDec 29, 2025
Volume4,940
Average Volume21,582
Open6,380.00
Previous Close6,400.00
Day's Range6,200.00 - 6,420.00
52-Week Range4,765.00 - 9,130.00
Beta0.55
RSI44.64
Earnings Daten/a

About RP Bio

RP Bio Inc., a bio-health company, engages in the research, development, manufacture, and sale of soft capsules in Korea and internationally. It offers animal, vegetable, antihistamine, and chewable soft capsules; hard capsules; and jelly and powder sticks; Urusa, flagship soft capsule; omega-3 and lutein products, and granule, effervescent granule, and stick type capsule powders. The company also provides cold and liver medicines; vitamins; blood circulation improvers; and pain relievers. The company was founded in 1983 and is headquartered in... [Read more]

Industry Pharmaceutical Preparations
Founded 1983
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 314140
Full Company Profile

Financial Performance

Financial Statements